Benefits of Hypoxic Culture on Bone Marrow Multipotent Stromal Cells

Overview

Journal Am J Blood Res

Specialty Hematology

Date 2012 Nov 3

PMID 23119226

Citations 66

Authors

Chih-Chien Tsai

Tu-Lai Yew

Der-Chi Yang

Wei-Hua Huang

Shih-Chieh Hung

Affiliations

Soon will be listed here.

Abstract

Cultivation of cells is usually performed under atmospheric oxygen tension; however, such a condition does not replicate the hypoxic conditions of normal physiological or pathological status in the body. Recently, the effects of hypoxia on bone marrow multipotent stromal cells (MSCs) have been investigated. In a long-term culture, hypoxia can inhibit senescence, increase the proliferation rate and enhance differentiation potential along the different mesenchymal lineages. Hypoxia also modulates the paracrine effects of MSCs, causing upregulation of various secretable factors, including the vascular endothelial growth factor and interleukin-6, and thereby promoting wound healing and diabetic fracture healing. Finally, hypoxia plays an important role in mobilization and homing of MSCs, primarily by its ability to induce stromal cell-derived factor-1 expression along with its receptor, CXCR4. After transplantation, an ischemic environment, that is the combination of hypoxia and lack of nutrition, can lead to apoptosis or cell death, which can be overcome by the hypoxic preconditioning of MSCs and overexpression of prosurvival genes like Akt, HO-1 and Hsp70. This review emphasizes that hypoxia is an important factor in all major aspects of stem cell biology, and the mechanism involved in the hypoxic inducible factor-1signaling pathway behind these responses is also discussed.

Citing Articles

A ceramic microbridge microfluidic chip to study osteogenic differentiation of mesenchymal stem cells in bioactive ceramic immune microenvironment.

Ye S, Cao Q, Ni P, Xiong S, Zhong M, Yuan T Bioact Mater. 2024; 45:520-533.

PMID: 39735335 PMC: 11681893. DOI: 10.1016/j.bioactmat.2024.11.005.

Regenerative potential of mesenchymal stromal cells in wound healing: unveiling the influence of normoxic and hypoxic environments.

Mahjoor M, Fakouri A, Farokhi S, Nazari H, Afkhami H, Heidari F Front Cell Dev Biol. 2023; 11:1245872.

PMID: 37900276 PMC: 10603205. DOI: 10.3389/fcell.2023.1245872.

Boosting therapeutic efficacy of mesenchymal stem cells in pulmonary fibrosis: The role of genetic modification and preconditioning strategies.

Mehrabani M, Mohammadyar S, Rajizadeh M, Bejeshk M, Ahmadi B, Nematollahi M Iran J Basic Med Sci. 2023; 26(9):1001-1015.

PMID: 37605719 PMC: 10440137. DOI: 10.22038/IJBMS.2023.69023.15049.

The Proliferation and Stemness of Peripheral Blood-Derived Mesenchymal Stromal Cells Were Enhanced by Hypoxia.

Wang P, Zhu P, Yu C, Wu J Front Endocrinol (Lausanne). 2022; 13:873662.

PMID: 35634504 PMC: 9134856. DOI: 10.3389/fendo.2022.873662.

Extracellular Vesicles from Hypoxic Pretreated Urine-Derived Stem Cells Enhance the Proliferation and Migration of Chondrocytes by Delivering miR-26a-5p.

Wan S, Bao D, Li J, Lin K, Huang Q, Li Q Cartilage. 2022; 13(2):19476035221077401.

PMID: 35548888 PMC: 9137301. DOI: 10.1177/19476035221077401.

References

Fehrer C, Brunauer R, Laschober G, Unterluggauer H, Reitinger S, Kloss F . Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell. 2007; 6(6):745-57. DOI: 10.1111/j.1474-9726.2007.00336.x. View

Prockop D . Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997; 276(5309):71-4. DOI: 10.1126/science.276.5309.71. View

Carrancio S, Lopez-Holgado N, Sanchez-Guijo F, Villaron E, Barbado V, Tabera S . Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol. 2008; 36(8):1014-21. DOI: 10.1016/j.exphem.2008.03.012. View

Dos Santos F, Andrade P, Boura J, Abecasis M, Lobato da Silva C, Cabral J . Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol. 2009; 223(1):27-35. DOI: 10.1002/jcp.21987. View

Holzwarth C, Vaegler M, Gieseke F, Pfister S, Handgretinger R, Kerst G . Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol. 2010; 11:11. PMC: 2827377. DOI: 10.1186/1471-2121-11-11. View

Jiang S, Haider H, Idris N, Salim A, Ashraf M . Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ Res. 2006; 99(7):776-84. DOI: 10.1161/01.RES.0000244687.97719.4f. View

Covello K, Kehler J, Yu H, Gordan J, Arsham A, Hu C . HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 2006; 20(5):557-70. PMC: 1410808. DOI: 10.1101/gad.1399906. View

Chow D, Wenning L, Miller W, Papoutsakis E . Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model. Biophys J. 2001; 81(2):675-84. PMC: 1301544. DOI: 10.1016/S0006-3495(01)75732-3. View

Ohnishi S, Yasuda T, Kitamura S, Nagaya N . Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells. Stem Cells. 2007; 25(5):1166-77. DOI: 10.1634/stemcells.2006-0347. View

10.

Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

11.

Pacary E, Petit E, Bernaudin M . Concomitant inhibition of prolyl hydroxylases and ROCK initiates differentiation of mesenchymal stem cells and PC12 towards the neuronal lineage. Biochem Biophys Res Commun. 2008; 377(2):400-406. DOI: 10.1016/j.bbrc.2008.09.145. View

12.

Rosova I, Dao M, Capoccia B, Link D, Nolta J . Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells. 2008; 26(8):2173-82. PMC: 3017477. DOI: 10.1634/stemcells.2007-1104. View

13.

Crisostomo P, Wang Y, Markel T, Wang M, Lahm T, Meldrum D . Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol. 2008; 294(3):C675-82. DOI: 10.1152/ajpcell.00437.2007. View

14.

Toma C, Pittenger M, Cahill K, Byrne B, Kessler P . Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105(1):93-8. DOI: 10.1161/hc0102.101442. View

15.

Wang X, Takagawa J, Lam V, Haddad D, Tobler D, Mok P . Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response. Sci Transl Med. 2011; 3(100):100ra90. PMC: 3350804. DOI: 10.1126/scitranslmed.3002814. View

16.

Tanimoto K, Makino Y, Pereira T, Poellinger L . Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J. 2000; 19(16):4298-309. PMC: 302039. DOI: 10.1093/emboj/19.16.4298. View

17.

Wang C, Yang H, Hsu H, Chen L, Tsai C, Tsai K . Mesenchymal stem cell-conditioned medium facilitates angiogenesis and fracture healing in diabetic rats. J Tissue Eng Regen Med. 2011; 6(7):559-69. DOI: 10.1002/term.461. View

18.

Lee S, Lee Y, Song C, Ahn Y, Han H . Role of FAK phosphorylation in hypoxia-induced hMSCS migration: involvement of VEGF as well as MAPKS and eNOS pathways. Am J Physiol Cell Physiol. 2010; 298(4):C847-56. DOI: 10.1152/ajpcell.00418.2009. View

19.

Kassir Y, Simchen G . Monitoring meiosis and sporulation in Saccharomyces cerevisiae. Methods Enzymol. 1991; 194:94-110. DOI: 10.1016/0076-6879(91)94009-2. View

20.

Valorani M, Germani A, Otto W, Harper L, Biddle A, Khoo C . Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential. Cell Tissue Res. 2010; 341(1):111-20. DOI: 10.1007/s00441-010-0982-8. View